Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study. [electronic resource]
Producer: 20171002Description: 232-8 p. digitalISSN:- 1567-7257
- Adult
- Anti-HIV Agents -- therapeutic use
- Antiretroviral Therapy, Highly Active
- Coinfection
- DNA, Viral -- genetics
- Evolution, Molecular
- Female
- Genome, Viral
- Genotype
- HIV -- drug effects
- HIV Infections -- drug therapy
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- drug therapy
- Humans
- Lamivudine -- therapeutic use
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Retrospective Studies
- South Africa
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.